Skip to main content
TipRanks
Go Ultimate75% OFF

Marvel Biosciences Corp (MRVL) Financial Statements

61 Followers

Marvel Biosciences Corp Financial Overview

Marvel Biosciences Corp's market cap is currently C$8.19M. The company's EPS TTM is C$-0.02; its P/E ratio is -4.87; Marvel Biosciences Corp has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Oct 25Oct 24Oct 23Oct 22Jul 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -547.37KC$ -302.02KC$ -887.52KC$ -1.38MC$ -613.10K
Operating IncomeC$ -1.25MC$ -1.22KC$ -2.32MC$ -2.54MC$ 806.33K
EBITDAC$ -1.94MC$ 1.22MC$ -2.25MC$ -2.55MC$ -1.25M
Net IncomeC$ -2.21MC$ -1.65KC$ -2.29MC$ -2.55MC$ -3.04M
Balance Sheet
Cash & Short-Term InvestmentsC$ 128.85KC$ 345.77KC$ 556.62KC$ 593.21KC$ 2.39M
Total AssetsC$ 326.71KC$ 491.31KC$ 672.39KC$ 913.54KC$ 2.47M
Total DebtC$ 2.31MC$ 1.71MC$ 1.00MC$ 0.00C$ 0.00
Net DebtC$ 2.18MC$ 1.36MC$ 443.38KC$ -593.21KC$ -2.39M
Total LiabilitiesC$ 4.33MC$ 3.32MC$ 2.39MC$ 718.00KC$ 112.48K
Stockholders' EquityC$ -4.01MC$ -2.83MC$ -1.72MC$ 195.54KC$ 2.36M
Cash Flow
Free Cash FlowC$ -1.15MC$ -1.18MC$ -1.33MC$ -2.19MC$ -1.37M
Operating Cash FlowC$ -1.15MC$ -1.18MC$ -1.33MC$ -2.19MC$ -1.37M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 381.57K
Financing Cash FlowC$ 933.41KC$ 968.64KC$ 1.30MC$ 394.00KC$ 3.16M

Currency in CAD

Marvel Biosciences Corp Earnings and Revenue History

-3.6M-2.4M-1.2M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin

Marvel Biosciences Corp Liabilities to Assets

02M4M6M0 %500 %1000 %1500 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Marvel Biosciences Corp Cash Flow

-3M-2M-1M01M2M3M4M2019202020212022202320242025OperatingInvestingFinancing

Marvel Biosciences Corp Forecast EPS vs Actual EPS

00000Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss